TruAlt Bioenergy Limited has delivered exceptional revenue performance for Q3FY26 ended December 31, 2025, achieving significant operational milestones while establishing a foundation for sustained growth. The company's latest results demonstrate successful completion of its capacity expansion program and strategic positioning across multiple bioenergy segments.

Strong Financial Performance with Operational Scale

TruAlt Bioenergy reported robust financial results for Q3FY26, with consolidated revenue reaching ₹713.24 crore compared to ₹415.11 crore in Q3FY25. Total income increased to ₹730.86 crore, representing 69.75% quarter-on-quarter growth driven by higher throughput following commissioning of grain integration capex and expanded plant operations.

Ethanol Business Achieves Full Operational Capacity

The company completed a key phase of operating consolidation in the ethanol segment during Q3FY26, with planned capital expenditure for grain-based integration fully commissioned. Four of the company's five ethanol plants were operational during the quarter, achieving capacity utilisation of over 95% on operating days. Unit 5 received its Consent to Operate on December 17, 2025, following which all ethanol plants are now fully operational.

With approximately 58 effective operating days during the quarter due to sugar crushing season commencing from mid-November, overall utilisation stood at approximately 60% on a gross-quarter basis. The company now operates on a stabilised platform with ability to support monthly ethanol production of approximately 5.5 to 6 crore litres, with no further capacity additions planned across the ethanol business.

Strategic Business Segment Performance

The CBG segment delivered strong performance with operating efficiencies meaningfully exceeding industry benchmarks. For nine months ended December 31, 2025, the business recorded total income of ₹30.97 crore, EBITDA margin of 63% and PAT margin of 43%, reflecting robustness and scalability of the operating model.

Sustainable Aviation Fuel Development Progress

TruAlt Bioenergy progressed significantly in the Sustainable Aviation Fuel segment during the quarter, advancing a technology licensing agreement with Honeywell UOP. Engineering design is underway for a proposed 100 million litres per annum SAF facility in Andhra Pradesh, with discussions being advanced with Sumitomo Corporation for potential equity participation.

The company is at an advanced stage of approvals and expects to receive ₹150 crore of viability gap funding under the PM JI-VAN scheme, which would strengthen project viability and execution readiness. This positions the company to capitalise on aviation industry's critical inflection point toward carbon emission reduction.

Retail Expansion and Future Readiness

In the biofuel retail segment, TruAlt Bioenergy received its oil marketing company licence and commissioned seven retail outlets within six months. Four additional stations are currently under development, with clear visibility to scale approximately 75 outlets from FY27 onwards. This expansion positions the company to be future-ready, aligned with expected adoption of flex-fuel in India and strengthening its presence in the B2C energy segment.

Nine-Month Performance and Outlook

For the nine months ended December 31, 2025, consolidated total income reached ₹1,187.05 crore compared to ₹1,047.85 crore in the previous year, representing 13.28% growth. EBITDA increased to ₹170.99 crore from ₹155.43 crore, up 10.01% year-over-year, while PAT stood at ₹35.92 crore compared to ₹34.94 crore in 9MFY25.

Managing Director Vijay Nirani commented that the quarter reflects meaningful progress in strengthening the company's operating foundation and enhancing earnings quality. The transition towards near year-round operations marks a structural shift for the business, improving operating predictability, efficiency and earnings visibility while maintaining focus on consistent execution and long-term value creation.

TruAlt Bioenergy Limited has announced a key leadership appointment, naming Mr. Monu Kumar as Interim Company Secretary and Compliance Officer effective January 9, 2026. The appointment was approved by the company's Board of Directors following a recommendation from the Nomination and Remuneration Committee during their meeting held on January 9, 2026.

Board Meeting Details

The board meeting that approved Mr. Kumar's appointment commenced at 4:30 PM and concluded at 5:15 PM on January 9, 2026. The company has fulfilled its regulatory obligations by informing both BSE Limited and the National Stock Exchange of India Limited about this key managerial personnel appointment under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment Terms and Duration

Mr. Kumar's appointment as Interim Company Secretary and Compliance Officer is effective immediately and will continue until a regular Compliance Officer is appointed or until further orders of the Board, whichever occurs earlier. The appointment details are summarized below:

Professional Background and Expertise

Mr. Monu Kumar brings substantial experience to his new role at TruAlt Bioenergy Limited. He is a qualified Company Secretary and Law Graduate with over 11 years of professional experience spanning multiple areas of corporate operations. His expertise encompasses several critical areas:

• Corporate governance and secretarial functions
• Legal and regulatory compliance across various entity types
• Experience with listed, unlisted, NBFC, and group companies
• Corporate restructuring and merger & acquisition activities
• Cross-border regulatory compliance and FEMA matters
• Transaction support and fund raising initiatives
• IPO and listing compliance requirements

Previous Professional Experience

Prior to joining TruAlt Bioenergy Limited, Mr. Kumar held positions with several notable organizations. His previous associations include Kurl-On, which operates as a material subsidiary of Sheela Foam Limited (a listed entity), Rungta Irrigation Limited, and Samara Realty Private Limited. This diverse experience across different sectors and company structures positions him well for his interim role.

Regulatory Compliance

The appointment has been made in full compliance with regulatory requirements, including Regulation 30 of the SEBI Listing Regulations and relevant SEBI circulars. TruAlt Bioenergy Limited has provided comprehensive disclosure details as required under the applicable regulations and has made the information available on the company's website at www.trualtbioenergy.com .

This interim appointment ensures continuity in the company's compliance and secretarial functions while the organization works toward identifying a permanent candidate for the role. Mr. Kumar's extensive background in corporate governance and regulatory compliance across various business environments makes him well-suited to handle the interim responsibilities effectively.